Quantitative Assessment of the Degree of Ductal Steal Using Celiac Artery Blood Flow to Left Ventricular Output Ratio in Preterm InfantsEl-Khuffash A.a · Higgins M.a · Walsh K.b · Molloy E.J.a
aDepartment of Neonatology, National Maternity Hospital, and bDepartment of Paediatric Cardiology, Our Lady’s Hospital for Sick Children, Dublin, Ireland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Determining the significance of a patent ductus arteriosus (PDA) remains difficult in preterm neonates and current echocardiographic markers give little information about ductal steal. We hypothesized that the relationship between celiac artery flow (CAF) and left ventricular output (LVO) in the presence of a PDA may determine haemodynamic significance. Objectives: To examine CAF to LVO ratio (CAF:LVO) in the presence and the absence of a PDA in preterm neonates, and to compare CAF:LVO to current echocardiographic markers of a significant PDA. Methods: This was a prospective observational study of neonates <1,500 g. Echocardiography was performed at 12 h and day 3. PDA, LVO and CAF were measured by echocardiography. The infants were divided into those who developed a significant PDA (PDA >1.4 mm and left atrial to aortic ratio >1.5 on day 3) and controls. A further assessment was carried out following successful PDA treatment with ibuprofen or surgical ligation. Results: A total of 33 infants were enrolled. 19 infants had a PDA (median gestation 27 weeks, birth weight 915 g), and 14 controls (gestation 28.7 weeks, birth weight 1,110 g). At 12 h, there was no difference in CAF, LVO or CAF:LVO. On day 3, there was a significant difference in CAF:LVO between PDA versus control groups. CAF:LVO significantly correlated with conventional markers of ductal significance. A CAF:LVO value of 0.10 had a sensitivity of 93% and a specificity of 78% for the presence of a significant PDA. Following successful PDA treatment CAF:LVO returned to levels similar to controls. Conclusion: CAF:LVO may be used to determine which PDA warrants treatment and serve as a marker of treatment success. Trials are needed to correlate CAF:LVO with outcome and the impact of basing PDA treatment on this ratio.
© 2007 S. Karger AG, Basel
- Van Overmeire B, Chemtob S: The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 2005;10:177–184.
- Clyman RI: Mechanisms regulating the ductus arteriosus. Biol Neonate 2006;89:330–335.
- Skelton R, Evans N, Smythe J: A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for patent ductus arteriosus. J Paediatr Child Health 1994;30:406–411.
- Alagarsamy S, Chhabra M, Gudavalli M, Nadroo AM, Sutija VG, Yugrakh D: Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants. J Perinat Med 2005;33:161–164.
- Shimada S, Kasai T, Hoshi A, Murata A, Chida S: Cardiocirculatory effects of patent ductus arteriosus in extremely low-birth-weight infants with respiratory distress syndrome. Pediatr Int 2003;45:255–262.
- Swarup J, Baker RW, Brozanski BS, Yanowitz TD: Asymmetry of cerebral blood flow velocity in low birth weight infants. Biol Neonate 2005;87:145–151.
- Walther FJ, Kim DH, Ebrahimi M, Siassi B: Pulsed Doppler measurement of left ventricular output as early predictor of symptomatic patent ductus arteriosus in very preterm infants. Biol Neonate 1989;56:121–128.
- Alverson DC, Eldridge MW, Johnson JD, Burstein R, Papile L, Dillon T, Yabek S, Berman W Jr: Effect of patent ductus arteriosus on left ventricular output in premature infants. J Pediatr 1983;102:754–757.
- Shimada S, Kasai T, Konishi M, Fujiwara T: Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr 1994;125:270–277.
- Iyer P, Evans N: Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus. Arch Dis Child 1994;70:F112–F117.
- Papile LA, Burstein J, Burstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 g. J Pediatr 1978;92:529–534.
El Hajjar HM, Vaksmann G, Rakza T, Kongolo G, Storme L: Severity of the ductal shunt: a comparison of different markers. Arch Dis Child 2005;90:F419–F422.
- Kluckow M, Evans N: Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995;127:774–779.
- Alverson DC, Eldridge MW, Johnson JD, Aldrich M, Angelus P, Berman W Jr: Noninvasive measurement of cardiac output in healthy preterm and term newborn infants. Am J Perinatol 1984;1:148–151.
- Evans N, Kluckow M: Early determinants of right and left ventricular output in ventilated preterm infants. Arch Dis Child 1996;74:F88–F94.
- Murdoch EM, Sinha AK, Shanmugalingam ST, Smith GC, Kempley ST: Doppler flow velocimetry in the superior mesenteric artery on the first day of life in preterm infants and the risk of neonatal necrotizing enterocolitis. Pediatrics 2006;118:1999–2003.
- Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K: Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child 2005;90:F235–F239.
- Kluckow M, Evans N: Superior vena cava flow in newborn infants: a novel marker of systemic blood flow. Arch Dis Child 2000;82:F182–F187.
- Osborn DA, Evans N, Kluckow M: Hemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatrics 2003;112:33–39.
- Hunt RW, Evans N, Rieger I, Kluckow M: Low superior vena cava flow and neurodevelopment at 3 years in very preterm infants. J Pediatr 2004;145:588–592.
- Greisen G: Autoregulation of cerebral blood flow in newborn babies. Early Hum Dev 2005;81:423–428.
- Van Overmeire B: Patent ductus arteriosus: how aggressive should we be? Neonatology 2007;91:318.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.